Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trial
Title:
Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trial
Author:
Leroux-Roels, Isabel Willems, Paul Waerlop, Gwenn Janssens, Yorick Tourneur, Jessika De Boever, Fien Bruhwyler, Jacques Alhatemi, Azhar Jacobs, Bart Nicolas, Florence Leroux-Roels, Geert Le Vert, Alexandre